Linitis plastica screening: Difference between revisions

	Linitis plastica Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Linitis plastica from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Staging
Diagnostic study of choice
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Linitis plastica screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Linitis plastica screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Linitis plastica screening
CDC on Linitis plastica screening
Linitis plastica screening in the news
Blogs on Linitis plastica screening
Directions to Hospitals Treating Linitis plastica
Risk calculators and risk factors for Linitis plastica screening

VisualWikitext

Revision as of 19:28, 20 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]

Overview

There is insufficient evidence to recommend routine screening for linitis plastica.

Screening

There is insufficient evidence to recommend routine screening for linitis plastica.

References

Template:WikiDoc Sources

@@ Line 4: / Line 4: @@
 ==Overview==
-Patients who have a relative with hereditary diffuse gastric [[adenocarcinoma]] (HDGC) should be screened earlier for ''CDH1'' gene mutations.<ref name=me>Hereditary diffuse gastric cancer. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/hereditary-diffuse-gastric-cancer#definition Accessed on December 10, 2015</ref>
+There is insufficient evidence to recommend routine screening for linitis plastica.
 ==Screening==
-*Patients who have a relative with hereditary diffuse gastric adenocarcinoma (HDGC) should be screened earlier for ''CDH1'' gene mutations.<ref name=me>Hereditary diffuse gastric cancer. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/hereditary-diffuse-gastric-cancer#definition Accessed on December 10, 2015</ref>
+There is insufficient evidence to recommend routine screening for linitis plastica.
-*Indication for prophylactic [[gastrectomy]] include CDH1 positive patients.<ref name="pmid20719348">{{cite journal| author=Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS| title=Prophylactic total gastrectomy for individuals with germline CDH1 mutation. | journal=Surgery | year= 2011 | volume= 149 | issue= 3 | pages= 347-55 | pmid=20719348 | doi=10.1016/j.surg.2010.07.005 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20719348  }} </ref>
-**The disease [[penetrance]] for the hereditary form is 80%, resulting in a very high risk of developing the cancer.
 ==References==

Linitis plastica screening: Difference between revisions

Revision as of 19:28, 20 January 2016

Overview

Screening

References

Navigation menu